posted
eFoodSafety.com, Inc. Named the ''Featured Stock of the Month'' in the September 2005 Issue of the KonLin Letter; The KonLin Letter Reiterates Its ''Strong Buy'' Recommendation of EFSF Stock; First Price Target - $2.00 Per 9/12/05
SCOTTSDALE, Ariz., Sep 12, 2005 (BUSINESS WIRE) -- Patricia Ross-Gruden, President and Chief Executive Officer of eFoodSafety.com, Inc. (OTCBB:EFSF), announced today that eFoodSafety.com, Inc. has been selected by The KonLin Letter as the Featured Stock of the Month for September 2005. The KonLin Letter reiterates its "Strong Buy" recommendation of EFSF stock.
The KonLin Letter, a 25-year-old investment advisory newsletter noted for its fundamental and technical analysis of individual stocks and market movements, does not accept compensation for its analyses of selected companies. The report includes a review of the latest developments of the Company, the Company's market position and potential advantages, along with fundamentals and statistics.
The KonLin Letter, published by Konrad Kuhn, cited the following reasons for its follow-up "Strong Buy" recommendation on EFSF:
-- EFSF is financially stronger having eliminated $300,000 in debt and over $100,000 in monthly expenses
-- Acquisition of MedElite, Inc. headed by Dr. Richard Goldfarb, M.D., FACS adds credibility to the management team and brings to the company a proven revenue-generating product, Talsyn(TM)-CI/bid Scar Cream, with limited competition in this niche $4 Billion scar cream market
-- Knock-Out Technologies, Ltd.'s Big Six Germicidal Plus and Anthrax Sporicidal products are moving closer to commercialization and ultimately sales
-- Dr. Goldfarb, the medical director of Bucks County Clinical Research Center could prove to be an important key for testing new products developed by the Knock-Out and MedElite subsidiaries, a hidden gem that Mr. Kuhn believes investors haven't come to realize yet
"As publisher of The KonLin Letter, I've recommended eFoodSafety.com, Inc. as the November 2004 Stock of the Month, the Stock of the Year for 2005, and now in a Follow-Up Report the September 2005 Stock of the Month - with all recommendations based on significant due diligence and my 30+ years of experience in low-priced stocks. I feel strongly in this company's successful ability to produce revolutionary products and technologies and continue to reiterate my Strong Buy recommendation. In light of the recent restructuring, my stance on EFSF's potential is even stronger," stated Konnie Kuhn.
"Within the past 30 days, we have made major strides to bring eFoodSafety.com, Inc. toward revenue generation and profitability. We are grateful that Mr. Kuhn was able to recognize the tremendous strides made, and that through his analysis, investors will recognize that the steps taken will enhance shareholder value and create a fundamentally stronger company," stated Patricia Ross-Gruden, President and CEO.
About Kon-Lin Research & Analysis Corp.
The KonLin Letter, www.KonLin.com, chooses low-priced stocks to analyze, with an emphasis on emerging growth and special situations poised for explosive price appreciation. The KonLin Letter has constantly been one of the leading publications on Wall Street. It has been rated one of the best performing market letters in the nation, offering a unique service that each month recommends five low-priced selections, including a featured stock of the month.
About eFoodSafety.com, Inc.
eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, and avian influenza. The sporicidal product has completed its final efficacy laboratory study requisite for EPA licensure; in the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's recently announced acquisition of MedElite, Inc. is expected to provide recurring revenue to the company. MedElite, Inc. distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and Worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com).
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
